Biodesix to report fourth quarter and full year 2022 financial results on march 6, 2023

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus on lung disease, announced today that it will release financial results for the fourth quarter and year ended december 31, 2022 before the open of trading on monday, march 6. biodesix's management will host a conference call and webcast to discuss its financial results and provide a general business update at 8:00 a.m. eastern time on the same day.
BDSX Ratings Summary
BDSX Quant Ranking